CAD 4.07
(-7.08%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -8.79 CAD | 87.68% |
2022 | -71.37 CAD | -771.43% |
2021 | -8.19 CAD | 81.78% |
2020 | -44.96 CAD | -12.79% |
2019 | -39.86 CAD | -1903.02% |
2018 | -1.99 CAD | -541.94% |
2017 | -0.31 CAD | -121.43% |
2016 | -0.14 CAD | -208.37% |
2015 | -0.05 CAD | 84.87% |
2014 | -0.30 CAD | 98.1% |
2013 | -15.77 CAD | -24349.61% |
2012 | -0.06 CAD | -201.4% |
2011 | -0.02 CAD | 11.2% |
2010 | -0.02 CAD | 71.34% |
2009 | -0.08 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -1.60 CAD | -55.34% |
2023 Q1 | -0.69 CAD | 94.61% |
2023 Q2 | -4.33 CAD | -527.54% |
2023 Q3 | -2.61 CAD | 39.72% |
2023 Q4 | -1.03 CAD | 60.54% |
2023 FY | - CAD | 87.68% |
2022 Q2 | -0.49 CAD | 90.65% |
2022 Q1 | -5.24 CAD | -256.46% |
2022 Q3 | -5.49 CAD | -1020.41% |
2022 Q4 | -12.80 CAD | -133.15% |
2022 FY | - CAD | -771.43% |
2021 Q2 | -0.03 CAD | -102.75% |
2021 FY | - CAD | 81.78% |
2021 Q1 | 1.02 CAD | 155.14% |
2021 Q3 | -0.30 CAD | -967.62% |
2021 Q4 | -1.47 CAD | -390.0% |
2020 Q3 | -2.43 CAD | -2600.0% |
2020 Q1 | -0.30 CAD | -123.81% |
2020 Q2 | -0.09 CAD | 70.0% |
2020 FY | - CAD | -12.79% |
2020 Q4 | -1.85 CAD | 23.87% |
2019 Q4 | 1.26 CAD | 460.0% |
2019 Q1 | -3.70 CAD | -277.55% |
2019 Q2 | -1.08 CAD | 70.81% |
2019 Q3 | -0.35 CAD | 67.59% |
2019 FY | - CAD | -1903.02% |
2018 Q2 | -1.52 CAD | -280.0% |
2018 Q4 | -0.98 CAD | -545.45% |
2018 Q3 | 0.22 CAD | 114.47% |
2018 Q1 | -0.40 CAD | -29.03% |
2018 FY | - CAD | -541.94% |
2017 Q2 | -0.01 CAD | 69.7% |
2017 Q3 | 0.01 CAD | 225.0% |
2017 FY | - CAD | -121.43% |
2017 Q1 | -0.03 CAD | 79.69% |
2017 Q4 | -0.31 CAD | -3200.0% |
2016 FY | - CAD | -208.37% |
2016 Q4 | -0.13 CAD | -533.33% |
2016 Q3 | 0.03 CAD | -40.0% |
2016 Q2 | 0.05 CAD | 231.23% |
2016 Q1 | -0.04 CAD | 25.59% |
2015 FY | - CAD | 84.87% |
2015 Q3 | -0.04 CAD | -159.17% |
2015 Q4 | -0.05 CAD | -44.23% |
2015 Q2 | 0.06 CAD | 200.0% |
2015 Q1 | 0.02 CAD | 101.22% |
2014 Q4 | -1.64 CAD | -2407.65% |
2014 FY | - CAD | 98.1% |
2014 Q1 | -0.03 CAD | 97.93% |
2014 Q3 | -0.07 CAD | -10.1% |
2014 Q2 | -0.06 CAD | -104.83% |
2013 Q4 | -1.40 CAD | -4864.54% |
2013 FY | - CAD | -24349.61% |
2013 Q1 | -0.04 CAD | -671.43% |
2013 Q2 | -0.01 CAD | 80.69% |
2013 Q3 | -0.03 CAD | -286.3% |
2012 Q3 | -0.01 CAD | 43.06% |
2012 FY | - CAD | -201.4% |
2012 Q2 | -0.02 CAD | -770.83% |
2012 Q4 | -0.00 CAD | 58.82% |
2012 Q1 | -0.00 CAD | 68.42% |
2011 Q3 | -0.01 CAD | -275.0% |
2011 Q1 | -0.00 CAD | 94.67% |
2011 Q2 | -0.00 CAD | -500.0% |
2011 Q4 | -0.01 CAD | 15.56% |
2011 FY | - CAD | 11.2% |
2010 Q1 | -0.00 CAD | 98.98% |
2010 Q4 | -0.01 CAD | 43.18% |
2010 FY | - CAD | 71.34% |
2010 Q3 | -0.01 CAD | -355.17% |
2010 Q2 | -0.00 CAD | -2800.0% |
2009 Q2 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q3 | -0.03 CAD | 0.0% |
2009 Q4 | -0.01 CAD | 61.42% |
Name | Eps | Eps Difference |
---|---|---|
Aurora Cannabis Inc. | -1.60 CAD | -449.375% |
Avicanna Inc. | -0.09 CAD | -9341.461% |
Avant Brands Inc. | -0.61 CAD | -1340.984% |
Cardiol Therapeutics Inc. | -0.44 CAD | -1897.727% |
Crescita Therapeutics Inc. | -0.10 CAD | -8869.388% |
Knight Therapeutics Inc. | -0.16 CAD | -5393.75% |
MediPharm Labs Corp. | -0.04 CAD | -24316.667% |
OrganiGram Holdings Inc. | -2.82 CAD | -211.702% |
Willow Biosciences Inc. | -0.10 CAD | -8690.0% |
Auxly Cannabis Group Inc. | -0.04 CAD | -19476.837% |